President, Chief Executive Officer & Director
Lawrence Mehren has served as the Chief Executive Officer and a Director of the Company since June 2012. Mr. Mehren served as Senior Vice President and Chief Financial Officer of Ventana Medical Systems, Inc. from 2007 until 2008 and as Head of Global Business from 2008 until 2011. Previously, he was Managing Director, Partner and head of P&M Corporate Finance’s life sciences practice. Prior to his tenure at P&M, Mr. Mehren worked in management positions with Gale Group, a division of The Thomson Corporation, as well as with Merrill Lynch. Mr. Mehren holds a B.A. in Political Science from the University of Arizona and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management.
Chief Financial Officer
Steve Reichling has served as the Chief Financial Officer of the Company since September 2012. Prior to joining the Company, Mr. Reichling served as general manager of Spring Bioscience Corp., a R&D and research products subsidiary of Roche Diagnostics. From January 2003 to December 2009, Mr. Reichling held various finance, accounting and operations leadership roles at Roche Diagnostics and Ventana Medical Systems, Inc., including Director of Finance and Operations, Manager of Business Development Finance, and head of Internal Audit and Sarbanes Oxley Compliance. From October 2002 to January 2003, Mr. Reichling was an auditor at Ernst & Young LLP. Mr. Reichling received his B.A. in accounting and entrepreneurship from the University of Arizona and is a Certified Public Accountant.
Head of Operations
Kurt Reinhardt has served as the Head of Operations of the Company since September 2012. Mr. Reinhardt served in a variety of roles for Ventana Medical Systems, from 1991 to 2012, including establishing the initial Manufacturing and Quality Systems, Program Management, and Reliability Engineering. Prior to that, Mr. Reinhardt worked at Rockwell International on the Space Shuttle and Advanced Space Propulsion Programs, and worked as an engineer at the Mare Island Naval Shipyard on fast attack submarines. Mr. Reinhardt holds a B.S. in Mechanical Engineering from the University of Arizona and an M.S. in Industrial Engineering with an emphasis in applied statistics from California State University.
Head of Discovery
Steve Metzger has been the Head of Discovery of the Company since September 2012. Mr. Metzger served as Research and Development Manager at the company since December 2007, and as Senior Scientist from 2001 to 2007. Previously, he was responsible for the Protein and DNA Sequencing Core Lab at Heska Corporation, Fort Collins, CO, and coordinated the integration of assay methods, software, and optical microscopy instrumentation for the force amplified biosensor program at the Naval Research Laboratory, Washington, D.C. Mr. Metzger is an ACS accredited chemist with a B.A. in Chemistry from The Colorado College.
Head of Product Development
Andrew Ghusson has served as the Head of Product Development of the Company since October 2012. Prior to his current position, Mr. Ghusson was with Ventana Medical Systems, Inc. for 12 years where he most recently served as the Vice President of Platform Development. Mr. Ghusson has been in the medical diagnostics product development field for more than 20 years, where he previously worked in leadership positions at Nova BioMedical and Becton Dickinson. Mr. Ghusson holds a B.S. and M.S. in Mechanical Engineering from the New Jersey Institute of Technology.
Head of Clinical Intervention Solutions
Pete Bantock serves as the Head of Clinical Intervention Solutions of the company. Previously he served as the Chief Culture Officer and Head of Human Resources for the Company since April 2015. Mr. Bantock served as Chief Commercial Officer at the company beginning July 2013 . Prior to Accelerate Diagnostics, Mr. Bantock served as Chief Commercial Officer and Senior Vice President, North American Commercial Operations for Ventana Medical Systems, Inc. Mr. Bantock has held a variety of commercial positions in the medical diagnostics and pharmaceutical industries over the past 20 years including leadership roles at Spring Bioscience and Abbott Diagnostics Division. Mr. Bantock holds a Bachelor’s Degree from Rhodes University, South Africa.
Head of Regulatory and Quality
Constance Bridges joined the company in January 2014 serving as the Head of Quality prior to her current role, Head of Regulatory and Quality. Ms. Bridges has over 25 years of medical device and biologic industry experience in the combined fields of clinical, regulatory, quality, and engineering. Prior to joining the Company, Ms. Bridges served in a variety of roles for Hologic including Director of Global Quality Systems, Director of Quality Systems, and Director of Clinical Operations. From 2001 to 2008, Ms. Bridges held various regulatory, quality, and compliance leadership roles at Focus Diagnostics, including Director of Regulatory Affairs. Prior to her tenure at Focus, Ms. Bridges worked in various positions of increasing responsibility at both Baxter and Johnson & Johnson. Ms. Bridges received her B.S. in Engineering from Kettering University, her M.B.A. from Pepperdine University, holds Regulatory Affairs Certification, and is a Certified Biomedical Auditor.
Senior Vice President and Head of Commercial Operations, Americas
Ron Price has served as Senior Vice President and Head of Commercial Operations, Americas since April of 2015. Mr. Price has over 20 years of commercial operations experience and a proven track record of leading sales and marketing teams to achieve double-digit revenue growth and strong bottom-line performance. Prior to joining the Company, Mr. Price served as Vice President, Commercial Operations for Roche Point of Care managing all commercial responsibilities across three separate product lifecycles. In addition, Ron held a number of sales, marketing, and leadership roles with Ventana Medical Systems from 2001 to 2012 following 5 years at Bayer Healthcare Diagnostics. Mr. Price holds a B.S. in Clinical Laboratory Sciences, Cytology from the University of Oklahoma.
Chief Scientific Officer
Romney Humphries, PhD, D(ABMM), M(ASCP) serves as the Chief Scientific Officer of the company. Prior to joining Accelerate, Dr. Humphries was the Section Chief for Clinical Microbiology and the Assistant Clinical Professor of Pathology and Laboratory Medicine at UCLA Medical Center. Her seven year career there included the roles of Associate Director, Clinical Microbiology Laboratory, and Clinical Instructor. Dr. Humphries is well known for her interest and publications in the area of antimicrobial susceptibility testing, new diagnostic technologies, and her work to address common issues faced by clinical microbiology laboratories. She is author of more than 100 scientific peer-reviewed publications in journals such as Clinical Infectious Diseases and Journal of Clinical Microbiology and serves on a number of working groups and committees including the American Society for Microbiology, the Clinical Laboratory and Standards Institute, the U.S. Food and Drug Administration, and the World Health Organization. Dr. Humphries received her B.S. in Biochemistry from the University of Lethbridge in Alberta, Canada and her PhD from the University of Calgary. She completed her postdoctoral study at the UCLA David Geffen Medical School, Clinical Microbiology CPEP Program.